Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dr. Bob Martin Show

June 29 Elon Musk’s Drug Test Debacle: Clean Bill of Health or Calculated Distraction? HR 2

30 Jun 2025

Description

Is Elon Musk’s viral drug test a clean bill of health—or a clever distraction? The billionaire’s ‘lol’-worthy post showing negative results for 22 substances comes amid explosive claims from the NewYork Times alleging ketamine abuse, psychedelic binges, and a ‘daily pill box’ of stimulants duringhis Trump White House days. But with urine tests only revealing days-old use, and Trump himselfbranding Musk a ‘big-time addict,’ the stakes are sky-high. Is this transparency or tactical PR? Diveinto the blurred lines between mental health treatment and misuse, the risks of ketamine’s darkside, and why the world’s richest man can’t escape the court of public opinion.The Cold Plunge Paradox: How Ice Baths—Loved by Millions—Might BeSecretly Sabotaging Your HealthThink ice baths are the ultimate wellness hack? Think again. From ancient Greek bathhouses toWim Hof’s viral challenges, cold plunges have been hailed for centuries as a cure-all—boostingrecovery, melting stress, and even burning fat. But shocking new research reveals a chilling twist:your post-plunge cravings could be packing on pounds, while icy dips might be undermining musclegrowth and straining your heart. Join us as we unravel the frosty truth behind this polarizing trend,from a groundbreaking study linking cold water to 200+ extra calories per session, to experts’urgent warnings about hidden risks. Is your self-care routine secretly backfiring? Tune in to discoverthe icy reality—before your next plunge.Dr. Bob and Dr. Brockman take calls and emails from listeners

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.